11-47358725-G-GCA
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 4P and 10B. PVS1_StrongBP6_ModerateBA1
The ENST00000533968.1(SPI1):c.611_612insTG(p.Met205AlafsTer24) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 940,472 control chromosomes in the GnomAD database, including 9,290 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.22 ( 4234 hom., cov: 27)
Exomes 𝑓: 0.15 ( 5056 hom. )
Consequence
SPI1
ENST00000533968.1 frameshift
ENST00000533968.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0410
Genes affected
SPI1 (HGNC:11241): (Spi-1 proto-oncogene) This gene encodes an ETS-domain transcription factor that activates gene expression during myeloid and B-lymphoid cell development. The nuclear protein binds to a purine-rich sequence known as the PU-box found near the promoters of target genes, and regulates their expression in coordination with other transcription factors and cofactors. The protein can also regulate alternative splicing of target genes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.172 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 11-47358725-G-GCA is Benign according to our data. Variant chr11-47358725-G-GCA is described in ClinVar as [Benign]. Clinvar id is 2688186.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.33 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPI1 | NM_003120.3 | c.493+118_493+119insTG | intron_variant | ENST00000378538.8 | |||
SPI1 | NM_001080547.2 | c.496+118_496+119insTG | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPI1 | ENST00000378538.8 | c.493+118_493+119insTG | intron_variant | 1 | NM_003120.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.219 AC: 32995AN: 150802Hom.: 4235 Cov.: 27
GnomAD3 genomes
AF:
AC:
32995
AN:
150802
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.208 AC: 25255AN: 121646Hom.: 1381 AF XY: 0.199 AC XY: 13092AN XY: 65788
GnomAD3 exomes
AF:
AC:
25255
AN:
121646
Hom.:
AF XY:
AC XY:
13092
AN XY:
65788
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.150 AC: 118168AN: 789558Hom.: 5056 Cov.: 11 AF XY: 0.149 AC XY: 61260AN XY: 410274
GnomAD4 exome
AF:
AC:
118168
AN:
789558
Hom.:
Cov.:
11
AF XY:
AC XY:
61260
AN XY:
410274
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.219 AC: 33004AN: 150914Hom.: 4234 Cov.: 27 AF XY: 0.225 AC XY: 16574AN XY: 73666
GnomAD4 genome
AF:
AC:
33004
AN:
150914
Hom.:
Cov.:
27
AF XY:
AC XY:
16574
AN XY:
73666
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 39% of patients studied by a panel of primary immunodeficiencies. Number of patients: 37. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at